PHA767491 HCl

CAS No. 942425-68-5

PHA767491 HCl( CAY-10572 hydrochloride )

Catalog No. M19277 CAS No. 942425-68-5

PHA-767491 is an effective ATP-competitive dual Cdc7/CDK9 inhibitor (IC50: 10/34 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 39 Get Quote
10MG 55 Get Quote
25MG 88 Get Quote
50MG 129 Get Quote
100MG 212 Get Quote
200MG 313 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    PHA767491 HCl
  • Note
    Research use only, not for human use.
  • Brief Description
    PHA-767491 is an effective ATP-competitive dual Cdc7/CDK9 inhibitor (IC50: 10/34 nM).
  • Description
    PHA-767491 is an effective ATP-competitive dual Cdc7/CDK9 inhibitor (IC50: 10/34 nM). It has ~20-fold selectivity against GSK3-β and CDK1/2, 50-fold selectivity against CDK5 and MK2, 100-fold selectivity against CHK2 and PLK1.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    CAY-10572 hydrochloride
  • Pathway
    Endocrinology/Hormones
  • Target
    Reductase
  • Recptor
    Cdk1| Cdk2| Cdk9| Cdc7| GSK-3β
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    942425-68-5
  • Formula Weight
    213.24
  • Molecular Formula
    C12H11N3O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 17.33 mg/mL 69.40 mM
  • SMILES
    Cl.O=C1NCCc2nc(cc12)c3ccncc3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Montagnoli A, et al. Nat Chem Biol, 2008, 4(6), 357-365.
molnova catalog
related products
  • Lidorestat

    Lidorestat (IDD-676) is an aldose reductase inhibitor (IC50: 5 nM) with effective, selective and oral activity. Lidorestat improves nerve conduction and reduces the formation of cataracts.

  • 12-O-Methylcarnosic ...

    12-O-Methylcarnosic acid is a diterpene carnosic acid isolated from the acetone extract of Salvia microphylla, is an active constituent of 5α-reductase inhibition with an IC50 value of 61.7 μM.12-O-Methylcarnosic acid has antioxidant activity, it is effective preventing gastric lesions.?

  • Minalrestat

    Minalrestat(ARI-509) is an orally active and potent aldose reductase inhibitor for the study of impaired microvascular reactivity in diabetic patients.